Ashish M. Kamat/euoncology.europeanurology.com
Dec 12, 2024, 08:11
Ashish M. Kamat: Defining New Endpoints and Designing Next-Generation Trials in MIBC
Ashish M. Kamat, Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD Anderson Cancer Center, shared on X:
“Join us for joint summit by the International Bladder Cancer Group (IBCG) and Global Society of Rare Genitourinary Tumors (GSRGT) at San Raffaele Hospital.
Defining New Endpoints and Designing Next-Generation Trials of Perioperative Therapies in Muscle-Invasive Bladder Cancer.
Kudos to Andrea Necchi for his vision and leadership in making this happen!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26